Venture Capital for Entrepreneurs

Event Information

Venture Capital for Entrepreneurs

Dates:
Session 1: Thursday, Nov. 29, 2007
Venture Capital Reality – Creating a Sustainable Business

Session 2: Wednesday, January 16, 2008
The Art of VC Relationships – Deal Structures and Raising Capital

Time: 4 p.m. - 8:30 p.m.

Fees: CED Members - One Session $45 / Both Sessions $65
Non Members - One Session $60 / Both Sessions $90

Location: North Carolina Biotechnology Center

Reservations: Required

Register online:

Venture Capital for Entrepreneurs, session 2 only

Registration Deadline: Online pre-event registration closes at 5 p.m. on the Friday preceding each event. No refunds after closing date.

Questions about your registration? Contact CED Registration by phone at 919.549.7500 ext. 114 or by email at registration@cednc.org.

CED’s Venture Capital for Entrepreneurs is a two-part program focused on starting and growing a venture-backed company. The program provides early stage entrepreneurs with the relevant knowledge and resources needed to attract funding and create value in today’s business environment.

The two-part program series is designed to offer something of value to entrepreneurs across diverse industry sectors. The first session is focused on creating a sustainable business and perfecting the pitch, and the second session covers deal structures and raising capital.

The interactive panel session format will be led by investors and experienced entrepreneurs who will offer valuable advice needed to sustain a high-growth company.

Session 1: Venture Capital Reality – Creating a Sustainable Business (Nov. 29, 2007)

View agenda for Session 1.

Session 2: The Art of VC Relationships – Deal Structures and Raising Capital (Jan. 16, 2008)

View agenda for Session 2.

- The ABCs of venture economics and valuation
- How to choose the right investor for your company
- Understanding term sheets
- Life as a venture-backed company

Confirmed Speakers*
*Partial List

Ryan Allis, iContact
John Bonfiglio, Ph.D., Argos Therapeutics
Jan Bouten, The Aurora Funds
Jud Bowman, Motricity
John Cambier, IDEA Fund
Jason Caplain, Southern Capitol Ventures
Steven Casey, North Carolina Biotechnology Center
Bryan da Frota , Chief Executive Officer, Prioria, Inc.
John Fogg, Hutchison Law Group
Vipin K. Garg, Ph.D., Tranzyme Pharma
David Griest, SJF Ventures
Justyn Kasierski, Hutchison Law Group
Garheng Kong, M.D., Ph.D, Intersouth Partners
Brooks Malone, Hughes Pittman & Gupton
Steve Nelson, Wakefield Group
Neal Page, Inlet Technologies
Caroline Horton Rockafellow, Hutchison Law Group
Michael Ramich, Frontier Capital
Adam Smith, Square 1 Bank
Wright Steenrod, Chrysalis Ventures
Michael Wasserman, H.I.G. Ventures
Ben Weinberger, Digitalsmiths
Scot Wingo, ChannelAdvisor
Janet Yang, Novak Biddle